Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms × nedaplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Nasopharyngeal Carcinoma 12 Esophageal Squamous Cell Carcinoma 7 Esophageal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 3 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrence 1 Neoplasms 1 Immunotherapy Esophagus Cancer 1 Hypopharyngeal Neoplasms 1 Hepatic Artery Infusion 1 Head and Neck Neoplasms 1 Advanced Non-squamous Non-Small-Cell Lung Cancer 1

Interventions

Surveys and Questionnaires 93 Exercise 84 Blood Specimen Collection 75 Radiotherapy 59 Gemcitabine 49 Standard of Care 48 Bevacizumab 48 Cisplatin 47 Carboplatin 43 Dexamethasone 42 Capecitabine 41 Paclitaxel 39 Cyclophosphamide 39 Interviews as Topic 38 pembrolizumab 37 Docetaxel 37 Oxaliplatin 34 Methods 33 Magnetic Resonance Spectroscopy 32 Irinotecan 32 Fluorouracil 32 Therapeutics 27 Radiosurgery 25 Nivolumab 25 Drug Therapy 25 Educational Status 23 Leucovorin 20 Surgical Procedures, Operative 19 Everolimus 19 Erlotinib Hydrochloride 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02777788 2017-10-10

TCM

Shanghai University of Traditional Chinese Medicine

Phase 2/3 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡